Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome

Zhengwei Wan(University of Electronic Science and Technology of China), Yuping Liu(University of Electronic Science and Technology of China), Yongju Ye(Lishui Central Hospital), Ping Shuai(University of Electronic Science and Technology of China), Tingting Zhang(Second Xiangya Hospital of Central South University), Yixuan Zhang(Nanjing Drum Tower Hospital), Ping Sun(University of Electronic Science and Technology of China), Yan Chen(Macau University of Science and Technology), Zhaochen Sun(University of Electronic Science and Technology of China), Jianhui Zhao(Zhejiang University), Dongyu Li(Wuhan Puai Hospital), Kangning Li(Zhejiang University), Li Pan(New York State Office of Mental Health), Xue Li(Department of Health), Jiali Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Huimin Zheng(Shanghai University of Traditional Chinese Medicine)
European Journal of Preventive Cardiology
February 19, 2024
10.1093/eurjpc/zwae066
Cited by 39

Related Papers

Regional variation limits applications of healthy gut microbiome reference ranges and disease models
|Nature Medicine|2018|980
Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
|BMJ|2021|809
Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation
|JMIR Medical Informatics|2019|558
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|534
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
|BMJ|2017|402